Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1927 1
1968 1
1974 1
1978 1
1979 3
1980 7
1981 4
1982 6
1983 3
1984 5
1985 12
1986 8
1987 5
1988 7
1989 6
1990 3
1991 4
1992 5
1993 4
1994 8
1995 5
1996 2
1997 2
1998 8
1999 7
2000 9
2001 3
2002 11
2003 7
2004 8
2005 10
2006 12
2007 8
2008 8
2009 8
2010 3
2011 10
2012 7
2013 7
2014 11
2015 7
2016 7
2017 3
2018 3
2019 1
2020 2
2021 1
2024 2
2025 0

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

253 results

Results by year

Filters applied: . Clear all
Page 1
Clinical correlates of CT imaging-derived phenotypes among lean and overweight patients with hepatic steatosis.
Song I, Thompson EW, Verma A, MacLean MT, Duda J, Elahi A, Tran R, Raghupathy P, Swago S, Hazim M, Bhattaru A, Schneider C, Vujkovic M, Torigian DA, Kahn CE, Gee JC, Borthakur A, Kripke CM, Carson CC, Carr R, Jehangir Q, Ko YA, Litt H, Rosen M, Mankoff DA, Schnall MD, Shou H, Chirinos J, Damrauer SM, Serper M, Chen J, Rader DJ; Penn Medicine BioBank; Witschey WRT, Sagreiya H. Song I, et al. Among authors: carson cc. Sci Rep. 2024 Jan 2;14(1):53. doi: 10.1038/s41598-023-49470-x. Sci Rep. 2024. PMID: 38167550 Free PMC article.
Targeting the IL-2 inducible kinase in melanoma; a phase 2 study of ibrutinib in systemic treatment-refractory distant metastatic cutaneous melanoma: preclinical rationale, biology, and clinical activity (NCI9922).
Moschos SJ, Eroglu Z, Khushalani NI, Kendra KL, Ansstas G, In GK, Wang P, Liu G, Collichio FA, Googe PB, Carson CC, McKinnon K, Wang HH, Nikolaishvilli-Feinberg N, Ivanova A, Arrowood CC, Garrett-Mead N, Conway KC, Edmiston SN, Ollila DW, Serody JS, Thomas NE, Ivy SP, Agrawal L, Dees EC, Abbruzzese JL. Moschos SJ, et al. Among authors: carson cc. Melanoma Res. 2021 Apr 1;31(2):162-172. doi: 10.1097/CMR.0000000000000726. Melanoma Res. 2021. PMID: 33661190 Free PMC article. Clinical Trial.
Why men's health?
Carson CC. Carson CC. Postgrad Med. 2020 Dec;132(sup4):1-3. doi: 10.1080/00325481.2020.1805867. Epub 2020 Nov 6. Postgrad Med. 2020. PMID: 33156726 No abstract available.
Identification of a Robust Methylation Classifier for Cutaneous Melanoma Diagnosis.
Conway K, Edmiston SN, Parker JS, Kuan PF, Tsai YH, Groben PA, Zedek DC, Scott GA, Parrish EA, Hao H, Pearlstein MV, Frank JS, Carson CC, Wilkerson MD, Zhao X, Slater NA, Moschos SJ, Ollila DW, Thomas NE. Conway K, et al. Among authors: carson cc. J Invest Dermatol. 2019 Jun;139(6):1349-1361. doi: 10.1016/j.jid.2018.11.024. Epub 2018 Dec 6. J Invest Dermatol. 2019. PMID: 30529013 Free PMC article.
Editorial Commentary.
Carson CC. Carson CC. Urol Pract. 2017 Mar;4(2):124. doi: 10.1016/j.urpr.2016.04.014. Epub 2016 Dec 6. Urol Pract. 2017. PMID: 37592648 No abstract available.
Editorial Comment.
Carson CC 3rd. Carson CC 3rd. J Urol. 2017 Feb;197(2):458. doi: 10.1016/j.juro.2016.08.139. Epub 2016 Nov 3. J Urol. 2017. PMID: 27818154 No abstract available.
253 results